关键信息
-
基因名
CD157
- 应用
-
别名
ADP-ribosyl cyclase; BST1; Cyclic ADP-ribose hydrolase 2; CD157
-
种属
Cynomolgus
-
表达系统
HEK293
-
标签
C-8*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A2K5VGB5
-
表达区间
G26-A289
-
蛋白长度
Partial
-
分子量
40-50 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
CD157, also known as bone marrow stromal antigen 1 (BSA-1), is a type II membrane glycoprotein belonging to the NAD+-glycohydrolase enzyme family. It is primarily expressed on the surface of immune cells, particularly in activated monocytes and macrophages, and is involved in various biological processes, including leukocyte migration, inflammation, and immune response regulation. The role of CD157 in the immune system has garnered attention due to its implications in both protective immunity and pathological conditions such as autoimmune diseases and cancer. Research into CD157 recombinant proteins focuses on elucidating its functional properties, interactions with other molecules, and potential therapeutic applications. By producing CD157 in a recombinant form, scientists aim to study its enzymatic activity, which is known to facilitate the production of immunomodulatory molecules, and to explore its role in cell signaling pathways. Furthermore, understanding the three-dimensional structure of CD157 can provide insights into its ligand-binding capabilities and help identify novel inhibitors or agonists. Thus, CD157 recombinant proteins serve as a valuable tool in immune-related research and may pave the way for the development of targeted therapies for diseases involving dysregulated immune responses.
